{"AlternateComparison":false,"RelatedProducts":false,"Specification":true,"FeatureBenefit":false}
BD SurePath™ BD SurePath™ liquid-based Pap test

ROVERS CERVEX-COMBI BRUSHES, 500 EA

Icon to close the modal
Support
Becton, Dickinson and Company
Phone Icon
0124-4124300
bd_india@bd.com
Modal Close Icon
Contact Us

 

 

Icon to close thank you modal
Thank you for contacting our sales team!
A sales representive will get in touch with you shortly.
Address
Location Icon
6th Floor Signature Tower - B, South City I, NH 8 Gurgaon, 122001, Haryana
Overview

The BD SurePath™ liquid-based Pap test provides advantages over conventional Pap smears and other liquid-based cytology (LBC) tests, resulting in greater disease detection.

true
Features and Benefits
Promotional Story
false
Specification

GTIN - Bag

08719189246490

25

GTIN - Shelfpack

18719189246497

500

GTIN - each

00382904914622

1


Quantity - Shelfpack

500


Shelf Life (Days)

0

GTIN

GTIN - Bag 08719189246490 25
GTIN - Shelfpack 18719189246497 500
GTIN - each 00382904914622 1

Packaging

Quantity - Shelfpack 500

Storage and Handling

Shelf Life (Days) 0
Resources
Related Products
RELATED PRODUCTS NOT AVAILABLE
References
  • BD PrepStain™ slide processor: direct-to-vial study population [product insert]. Franklin Lakes, NJ: Becton, Dickinson and Company; 2016.
  • Fremont-Smith M, Marino J, Griffin B, Spencer L, Bolick D. Comparison of the Surepath liquid-based Papanicolaou smear with the conventional Papanicolaou smear in a multisite direct-to-vial study. Cancer. 102:269-279.
  • Nygård JF, Sauer T, Nygård M, Skare GB, Thoresen S Ø. CIN 2/3 and cervical cancer in an organised screening programme after an unsatisfactory or a normal Pap smear: a seven-year prospective study of the Norwegian population-based screening programme. J Med Screen. 2004;11(2):70-76.
  • Nance KV. Evolution of Pap testing at a community hospital: a ten year experience. Diagn Cytopathol. 2007:35(3):148-153.
true
true